CD19 and rheumatoid arthritis: It has been shown that human CD19+CD24hiCD38hi B cells possessed regulatory capacity and that patients with Systemic Lupus Erythematosus (SLE) (27) or with inactive RA (14) had similar peripheral blood levels of CD19+CD24hiCD38hi B cells to those of healthy individuals.